Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 6 | 2019 | 270 | 2.430 |
Why?
|
| Membrane Proteins | 6 | 2019 | 466 | 2.200 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 122 | 1.750 |
Why?
|
| RNA, Messenger | 16 | 2019 | 646 | 1.240 |
Why?
|
| Prostate | 3 | 2019 | 51 | 1.100 |
Why?
|
| Androgens | 2 | 2016 | 47 | 0.950 |
Why?
|
| Carbon | 2 | 2016 | 93 | 0.920 |
Why?
|
| Sarcosine Dehydrogenase | 2 | 2013 | 4 | 0.820 |
Why?
|
| Saccharomyces cerevisiae Proteins | 8 | 2000 | 110 | 0.680 |
Why?
|
| Transcriptome | 1 | 2019 | 199 | 0.590 |
Why?
|
| DNA-Binding Proteins | 7 | 1998 | 482 | 0.590 |
Why?
|
| Saccharomyces cerevisiae | 12 | 2000 | 172 | 0.570 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 309 | 0.550 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 376 | 0.530 |
Why?
|
| Cell Movement | 2 | 2014 | 353 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 441 | 0.500 |
Why?
|
| Neuroendocrine Tumors | 1 | 2015 | 29 | 0.500 |
Why?
|
| Carcinogenesis | 1 | 2015 | 79 | 0.490 |
Why?
|
| Sarcosine | 2 | 2013 | 4 | 0.490 |
Why?
|
| Protein Biosynthesis | 10 | 2013 | 106 | 0.490 |
Why?
|
| 5' Untranslated Regions | 2 | 2013 | 9 | 0.480 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 49 | 0.470 |
Why?
|
| Integrin alphaV | 1 | 2014 | 3 | 0.470 |
Why?
|
| Integrin beta3 | 1 | 2014 | 7 | 0.470 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2014 | 18 | 0.460 |
Why?
|
| Fungal Proteins | 8 | 2000 | 72 | 0.460 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 180 | 0.450 |
Why?
|
| Bacterial Proteins | 6 | 1995 | 474 | 0.450 |
Why?
|
| Prokaryotic Initiation Factor-2 | 1 | 2013 | 2 | 0.430 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 284 | 0.420 |
Why?
|
| RNA-Binding Proteins | 4 | 2000 | 82 | 0.410 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2000 | 23 | 0.350 |
Why?
|
| Plasmids | 6 | 1998 | 121 | 0.330 |
Why?
|
| Trans-Activators | 6 | 2000 | 113 | 0.320 |
Why?
|
| RNA, Fungal | 6 | 2000 | 8 | 0.320 |
Why?
|
| Male | 7 | 2019 | 12868 | 0.290 |
Why?
|
| Open Reading Frames | 2 | 2013 | 38 | 0.290 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 1263 | 0.270 |
Why?
|
| DNA Helicases | 3 | 1995 | 51 | 0.240 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 1995 | 152 | 0.240 |
Why?
|
| Escherichia coli Proteins | 2 | 1995 | 113 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 310 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2015 | 114 | 0.220 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 486 | 0.220 |
Why?
|
| Proteins | 3 | 1995 | 244 | 0.210 |
Why?
|
| Escherichia coli | 4 | 1995 | 328 | 0.210 |
Why?
|
| Transcription, Genetic | 8 | 2000 | 400 | 0.190 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 216 | 0.190 |
Why?
|
| Molecular Sequence Data | 10 | 2000 | 1036 | 0.190 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1996 | 26 | 0.190 |
Why?
|
| DNA Replication | 4 | 1998 | 49 | 0.190 |
Why?
|
| Mice | 4 | 2015 | 4405 | 0.190 |
Why?
|
| Mutation | 6 | 2000 | 819 | 0.180 |
Why?
|
| Base Sequence | 9 | 2000 | 573 | 0.180 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2000 | 2 | 0.180 |
Why?
|
| Humans | 8 | 2024 | 26828 | 0.180 |
Why?
|
| Bacterial Toxins | 3 | 1995 | 265 | 0.180 |
Why?
|
| Cell Proliferation | 2 | 2014 | 767 | 0.180 |
Why?
|
| Nanoparticles | 1 | 2024 | 273 | 0.170 |
Why?
|
| Datasets as Topic | 1 | 2019 | 21 | 0.170 |
Why?
|
| Frameshifting, Ribosomal | 4 | 2000 | 4 | 0.160 |
Why?
|
| Prostatectomy | 1 | 2019 | 83 | 0.160 |
Why?
|
| Protein Kinases | 2 | 1998 | 143 | 0.160 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 225 | 0.160 |
Why?
|
| Cell Cycle | 1 | 2019 | 155 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2016 | 1344 | 0.150 |
Why?
|
| Virus Replication | 1 | 1998 | 55 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 472 | 0.150 |
Why?
|
| Peptide Chain Termination, Translational | 2 | 1999 | 2 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 450 | 0.140 |
Why?
|
| Animals | 5 | 2015 | 9957 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 439 | 0.140 |
Why?
|
| Prognosis | 1 | 2019 | 759 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1995 | 20 | 0.130 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 88 | 0.130 |
Why?
|
| NIH 3T3 Cells | 2 | 2014 | 44 | 0.120 |
Why?
|
| Regeneration | 1 | 2015 | 76 | 0.120 |
Why?
|
| R Factors | 2 | 1991 | 2 | 0.120 |
Why?
|
| Cytological Techniques | 1 | 2014 | 6 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 453 | 0.120 |
Why?
|
| Cell Shape | 1 | 2014 | 15 | 0.120 |
Why?
|
| Focal Adhesions | 1 | 2014 | 14 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 1924 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 110 | 0.110 |
Why?
|
| Models, Genetic | 6 | 2000 | 123 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 129 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 253 | 0.110 |
Why?
|
| Methotrexate | 1 | 2013 | 32 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 324 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 46 | 0.110 |
Why?
|
| Protein Subunits | 1 | 2013 | 40 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2013 | 25 | 0.110 |
Why?
|
| Codon | 4 | 2001 | 22 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 131 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 77 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2429 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 503 | 0.100 |
Why?
|
| Protein Binding | 3 | 2011 | 631 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2013 | 558 | 0.100 |
Why?
|
| F Factor | 1 | 1991 | 1 | 0.090 |
Why?
|
| Glycine | 1 | 2011 | 31 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2011 | 171 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 283 | 0.090 |
Why?
|
| Apoptosis | 1 | 2014 | 739 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1393 | 0.090 |
Why?
|
| Aged | 1 | 2019 | 5159 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 1475 | 0.080 |
Why?
|
| Middle Aged | 1 | 2019 | 6813 | 0.070 |
Why?
|
| Adult | 1 | 2019 | 7381 | 0.070 |
Why?
|
| Antiviral Agents | 2 | 1998 | 104 | 0.070 |
Why?
|
| Point-of-Care Systems | 1 | 2024 | 20 | 0.060 |
Why?
|
| Codon, Nonsense | 2 | 2000 | 11 | 0.060 |
Why?
|
| DNA, Bacterial | 2 | 1998 | 301 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 108 | 0.060 |
Why?
|
| Nanomedicine | 1 | 2024 | 62 | 0.050 |
Why?
|
| Liposomes | 1 | 2024 | 142 | 0.050 |
Why?
|
| RNA Helicases | 2 | 2000 | 8 | 0.050 |
Why?
|
| Phosphoglycerate Kinase | 3 | 2000 | 4 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2001 | 33 | 0.050 |
Why?
|
| Genetic Code | 1 | 2000 | 2 | 0.050 |
Why?
|
| Ribosomes | 1 | 2000 | 31 | 0.050 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2000 | 3 | 0.040 |
Why?
|
| Alleles | 2 | 1998 | 347 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 1996 | 149 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2000 | 152 | 0.040 |
Why?
|
| Paromomycin | 1 | 1998 | 1 | 0.040 |
Why?
|
| Genes, Fungal | 2 | 1995 | 7 | 0.040 |
Why?
|
| Peptide Termination Factors | 1 | 1998 | 2 | 0.040 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 1998 | 4 | 0.040 |
Why?
|
| Viruses | 1 | 1998 | 18 | 0.040 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1998 | 6 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 205 | 0.040 |
Why?
|
| Sparsomycin | 1 | 1997 | 1 | 0.040 |
Why?
|
| Anisomycin | 1 | 1997 | 3 | 0.040 |
Why?
|
| Peptidyl Transferases | 1 | 1997 | 2 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1997 | 13 | 0.040 |
Why?
|
| RNA Viruses | 1 | 1997 | 5 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1998 | 511 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 143 | 0.030 |
Why?
|
| Phenotype | 1 | 1998 | 666 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 1998 | 110 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 200 | 0.030 |
Why?
|
| Pseudomonas | 1 | 1995 | 13 | 0.030 |
Why?
|
| Histones | 1 | 1995 | 90 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2014 | 28 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 29 | 0.030 |
Why?
|
| Terminator Regions, Genetic | 1 | 1991 | 1 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 1991 | 24 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1991 | 90 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1991 | 228 | 0.020 |
Why?
|
| Genotype | 1 | 1991 | 442 | 0.020 |
Why?
|
| Kinetics | 1 | 1991 | 538 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 674 | 0.020 |
Why?
|
| Lac Operon | 2 | 2000 | 4 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2000 | 88 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2000 | 9 | 0.010 |
Why?
|
| Genes | 1 | 2000 | 35 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 49 | 0.010 |
Why?
|
| Untranslated Regions | 1 | 2000 | 1 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2000 | 3 | 0.010 |
Why?
|
| RNA Stability | 1 | 2000 | 27 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 57 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 109 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 135 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1998 | 3 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1998 | 7 | 0.010 |
Why?
|
| Virus Physiological Phenomena | 1 | 1998 | 1 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 245 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 12 | 0.010 |
Why?
|
| Models, Biological | 1 | 1999 | 446 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 627 | 0.010 |
Why?
|
| Aminohydrolases | 1 | 1995 | 2 | 0.010 |
Why?
|
| Formate-Tetrahydrofolate Ligase | 1 | 1995 | 2 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 1995 | 2 | 0.010 |
Why?
|
| Pyrophosphatases | 1 | 1995 | 5 | 0.010 |
Why?
|
| Replicon | 1 | 1995 | 7 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1995 | 47 | 0.010 |
Why?
|
| Half-Life | 1 | 1995 | 32 | 0.010 |
Why?
|
| Exodeoxyribonuclease V | 1 | 1995 | 3 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 37 | 0.010 |
Why?
|
| Exodeoxyribonucleases | 1 | 1995 | 6 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 24 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1995 | 34 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1995 | 65 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 90 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 106 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 129 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 408 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 333 | 0.010 |
Why?
|
Ruiz-Echevarria's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_